Additional Information for Erlotinib Hydrochloride Tablets
Erlotinib Hydrochloride Tablets are a type of medication that falls under the supply class Drugs And Biologicals in the supply group Medical, Dental, And Veterinary Equipment And Supplies. Erlotinib Hydrochloride is the active ingredient in these tablets, and it is primarily used in the treatment of certain types of cancer.
Erlotinib Hydrochloride is classified as a tyrosine kinase inhibitor, which means it works by blocking the action of an enzyme called epidermal growth factor receptor (EGFR). This enzyme is involved in the growth and spread of cancer cells. By inhibiting EGFR, Erlotinib Hydrochloride helps to slow down or stop the growth of cancer cells.
These tablets are typically prescribed by healthcare professionals for the treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer. They are usually taken orally, with or without food, as directed by the healthcare provider.
It is important to note that Erlotinib Hydrochloride Tablets may have potential side effects, including skin rash, diarrhea, nausea, vomiting, and fatigue. It is essential to discuss any concerns or potential side effects with a healthcare professional before starting this medication.
As with any medication, it is crucial to follow the prescribed dosage and instructions provided by the healthcare provider. If you have any further questions or need more information, it is recommended to consult with a healthcare professional or pharmacist.
Related Item Names for INC 68478 Erlotinib Hydrochloride Tablets
NATO Stock Numbers with Item Name 68478 Erlotinib Hydrochloride Tablets Page 1 of 1
- 3400936923232
- RNCC: 3 | RNVC: 2 | DAC: 4
- 3400936923461
- RNCC: 3 | RNVC: 2 | DAC: 4
- 3400936923522
- RNCC: 3 | RNVC: 2 | DAC: 4